Page last updated: 2024-09-04

yttria and isoproterenol

yttria has been researched along with isoproterenol in 1 studies

Compound Research Comparison

Studies
(yttria)
Trials
(yttria)
Recent Studies (post-2010)
(yttria)
Studies
(isoproterenol)
Trials
(isoproterenol)
Recent Studies (post-2010) (isoproterenol)
327123430,7808032,640

Protein Interaction Comparison

ProteinTaxonomyyttria (IC50)isoproterenol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.246
Beta-1 adrenergic receptorHomo sapiens (human)0.333
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)1.77
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-2 adrenergic receptorCanis lupus familiaris (dog)0.6667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Godugu, C; Khurana, A; Kumari, P1

Other Studies

1 other study(ies) available for yttria and isoproterenol

ArticleYear
Nanoyttria attenuates isoproterenol-induced cardiac injury.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:23

    Topics: Animals; Cardiotoxicity; Cytokines; Gene Expression Regulation; Heart; Heart Injuries; Hydroxyproline; Isoproterenol; Male; Mice; Myocardial Infarction; Nanoparticles; Oxidative Stress; Particle Size; RAW 264.7 Cells; Surface Properties; Yttrium

2018